Vertex Prescription drugs Included (VRTX) Q1 2026 Earnings Name Might 4, 2026 4:30 PM EDT
Firm Members
Susie Lisa – Senior Vice President of Investor Relations
Reshma Kewalramani – CEO, President & Director
Duncan J. McKechnie – Chief Business Officer, Head of North America Business & Govt VP
Charles Wagner – Govt VP, COO & CFO
Convention Name Members
Jessica Fye – JPMorgan Chase & Co, Analysis Division
Salveen Richter – Goldman Sachs Group, Inc., Analysis Division
Brian Abrahams – RBC Capital Markets, Analysis Division
Geoffrey Meacham – Citigroup Inc., Analysis Division
Cory Kasimov – Evercore ISI Institutional Equities, Analysis Division
Michael Yee – UBS Funding Financial institution, Analysis Division
Tazeen Ahmad – BofA Securities, Analysis Division
Evan Seigerman – BMO Capital Markets Fairness Analysis
David Risinger – Leerink Companions LLC, Analysis Division
Terence Flynn – Morgan Stanley, Analysis Division
Eliana Merle – Barclays Financial institution PLC, Analysis Division
Presentation
Operator
Good day, and welcome to the Vertex Prescription drugs First Quarter 2026 Earnings Name. [Operator Instructions] Please notice this occasion is being recorded. I might now like to show the convention over to Ms. Susie Lisa. Please go forward.
Susie Lisa
Senior Vice President of Investor Relations
Good night all. My title is Susie Lisa, and because the Senior Vice President of Investor Relations, it’s my pleasure to welcome you to our first quarter 2026 monetary outcomes convention name. On tonight’s name, making ready remarks, now we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Charlie Wagner, Chief Working Officer and Chief Monetary Officer; and Duncan McKechnie, Chief Business Officer.
We suggest that you just entry the webcast slides as you hearken to this name. The decision is being recorded, and a replay will likely be accessible on our web site. We’ll make forward-looking statements on this name which can be topic to the dangers and uncertainties mentioned intimately in at the moment’s press launch and in our filings with the
